亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台,协助业界发掘知识产权贸易商机,并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权,或是制造商需要购买技术以提高操作效能,又或是知识产权配套服务供应商,你将会从本网站发掘到有用的知识产权贸易资讯。

Structure-Activity Relationships of Azaindenoisoquinolines

详细技术说明
A novel process for synthesizing multiple Topoisomerase I inhibitors that have optimized structures for the greatest inhibitory activity and cytoxicity towards dividing cells was developed.
*Abstract

Topoisomerase I is an important protein found in the cell, and used to unwind and reduce torsional stress on DNA as it is being replicated. Topoisomerase I inhibitors are a useful chemotherapy agent, because cells that are constantly dividing, like cancer cells, are much more susceptible to attack; cell death will occur when topoisomerase I is inhibited. Topoisomerase I inhibitors make up a large portion of the chemotherapy market, because they can be used to target a wide variety of proliferating tumors. The characteristic of uninhibited division is a common feature in cancer that can be targeted without needing a specific marker for each cancer cell type. As more information becomes readily available, it is becoming apparent that within tumors there is a heterogeneous population of cells populating the primary tumor and the secondary tumors.

Purdue University researchers have developed a novel process for synthesizing four topoisomerase I inhibitors, and have optimized their structures for the greatest inhibitory activity and cytoxicity towards dividing cells. The compounds consist of 7-, 8-, 9-, and 10-azaindenoisoquinoline structures.

Advantages:
-Topoisomerase I is a proven target for cancer therapy
-Azaindenoisoquinolines have enhanced chemical stability and effectiveness over other Topoisomerase I inhibitors

国家/地区
美国

欲了解更多信息,请点击 这里
移动设备